Endocrine & Metabolic Imaging
Leading Endocrine & Metabolic Imaging CRO
- Board-certified radiologists and endocrinologists demonstrating extensive clinical trial experience with complex CT, MRI and DXA assessments (Bone Mineral Density and Total Body Composition)
- In-house, registered CT, MRI and DXA technologists who maintain a widespread knowledge in qualifying sites with customized & advanced data and acquisition protocols
- Integrative team of technologists, physicians, and medical physicists collectively possessing years of experience with imaging studies, that utilize the CT, MRI and DXA modalities, and their respective analysis and quality control checks
- Imaging project managers that specialize in managing imaging trials utilizing these modalities, designing and testing novel phantoms specifically for hepatic fat fraction assessment in MR Imaging
Streamlined Process
- Standardization of CT, MRI and DXA image acquisition protocols across global sites
- Imaging Review Charter
- 24/7 global site management
- Rigorous quality control and validation process
- Abide by Metrics Champion Consortium (MCC)
Integrated Technology
- Validated analytical workstations dedicated to CT/MR/DXA data analysis
- Seamless integration with other study-related services such as IVRS (ClinTrak®)
- Cloud-based image transmission system with zero local IT footprint (ClinTrak Imaging)
Expert Quality
SOP-driven processes
CFR Part 11 compliant and fully-validated imaging system for clinical trials
Dedicated imaging QA officers
Endocrine & Metabolic Imaging Experience
Modalities
- Computed Tomography (CT)
- Magnetic Resonance Elastography (MRE)
- Magnetic Resonance Imaging (MRI)
- Dual-Energy X-Ray Absorptiometry (DXA)
- Cardiac Safety: ECG, Holter TQT
- Ambulatory Blood Pressure
Sample Specialties
- Hyperlipidemia
- Nonalcoholic Steatohepatitis (NASH)
- Rare Endocrine Disorders
- Diabetes
- Obesity
- Chronic Kidney Disease
- Acromegaly
Response Criteria
Medpace Core Laboratories provide imaging analysis for metabolic disorders such as diabetes, obesity, nonalcoholic fatty liver disease (NAFLD), and nonalcoholic steatohepatitis (NASH). Our metabolic imaging endpoint measurements include hepatic fat fraction, hepatic fibrosis, bone mineral density, and total body composition. Our cardiac safety solutions for metabolic disorders include TQT Studies, ambulatory ECG monitoring and ambulatory blood pressure monitoring.
